We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

234 hedge funds and large institutions have $3.41B invested in Jazz Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 234 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

57% less call options, than puts

Call options by funds: $26.3M | Put options by funds: $60.9M

Holders
234
Holders Change
+234
Holders Change %
–
% of All Funds
7.64%
Holding in Top 10
10
Holding in Top 10 Change
+10
Holding in Top 10 Change %
% of All Funds
0.33%
New
234
Increased
–
Reduced
–
Closed
–
Calls
$26.3M
Puts
$60.9M
Net Calls
-$34.6M
Net Calls Change
-$34.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AAM
151
Advisors Asset Management
Colorado
$791K +$703K +11,505 New
CWM
152
Calamos Wealth Management
Illinois
$789K +$702K +11,479 New
SCM
153
Stux Capital Management
New York
$777K +$691K +11,300 New
BNP Paribas Financial Markets
154
BNP Paribas Financial Markets
France
$750K +$667K +10,916 New
PPA
155
Parametric Portfolio Associates
Washington
$716K +$637K +10,420 New
URS
156
Utah Retirement Systems
Utah
$646K +$575K +9,400 New
MCM
157
McKinley Capital Management
Alaska
$636K +$566K +9,256 New
SAG
158
Sterne Agee Group
Alabama
$623K +$554K +9,070 New
CCMH
159
Cornerstone Capital Management Holdings
New York
$570K +$507K +8,293 New
Tudor Investment Corp
160
Tudor Investment Corp
Connecticut
$564K +$501K +8,200 New
Principal Financial Group
161
Principal Financial Group
Iowa
$532K +$473K +7,735 New
Nomura Holdings
162
Nomura Holdings
Japan
$521K +$463K +7,570 New
APU
163
Alpine Partners USVI
U.S. Virgin Islands
$492K +$438K +7,168 New
Commonwealth Equity Services
164
Commonwealth Equity Services
Massachusetts
$491K +$437K +7,148 New
BA
165
BlackRock Advisors
Delaware
$486K +$432K +7,073 New
CA
166
Commerzbank Aktiengesellschaft
Germany
$478K +$425K +6,957 New
HIM
167
Hillsdale Investment Management
Ontario, Canada
$443K +$394K +6,452 New
PI
168
Placemark Investments
Illinois
$434K +$387K +6,329 New
FAM
169
Fortaleza Asset Management
Illinois
$430K +$383K +6,260 New
BIM
170
BRC Investment Management
Colorado
$426K +$379K +6,196 New
ZIM
171
Zacks Investment Management
Illinois
$425K +$378K +6,186 New
CAS
172
CTC Alternative Strategies
Illinois
$419K +$373K +6,100 New
B
173
Barings
North Carolina
$412K +$367K +6,000 New
HI
174
HBK Investments
Texas
$412K +$367K +6,000 New
FQ
175
First Quadrant
California
$380K +$338K +5,525 New
5 6
7
8 9

JAZZ Hedge Fund Activity: Q2 2013 in Review

234 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q2 2013, worth a combined $3.41B.

Buyers outnumbered sellers: 234 funds opened new JAZZ positions and 0 closed out — a net gain of 234 holders — while 0 added to existing stakes and 0 trimmed.

  • 234 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $3.41B of Jazz Pharmaceuticals stock for Q2 2013.
  • 234 funds opened new Jazz Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +234 holders.

Based on aggregated 13F filings for Q2 2013.